Skip to main content
Livermore
Livermore
ZHEN

First Manhattan Co

SEC CIK
0000728083
Latest filing
Aug 14, 2026

CLSD holding history

Clearside Biomedical, Inc. in every 13F filed by First Manhattan Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLSD overviewAll 13F holders of CLSDFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of CLSD by First Manhattan Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−22,846−100.0%Sold outHolders
Q3 202522,846$90.7K<0.1%00.0%UnchangedConverted for a 1-for-15 splitHolders
Q2 2025342,725$274.2K<0.1%00.0%UnchangedHolders
Q1 2025342,725$314.6K<0.1%−62,943−15.5%ReducedHolders
Q4 2024405,668$385.4K<0.1%−260,474−39.1%ReducedHolders
Q3 2024666,142$846.0K<0.1%+491,142+280.7%AddedHolders
Q2 2024175,000$227.5K<0.1%00.0%UnchangedHolders
Q1 2024175,000$267.8K<0.1%00.0%UnchangedHolders
Q4 2023175,000$204.8K<0.1%00.0%UnchangedHolders
Q3 2023175,000$152.2K<0.1%00.0%UnchangedHolders
Q2 2023175,000$196.0K<0.1%00.0%UnchangedHolders
Q1 2023175,000$182.0K<0.1%00.0%UnchangedHolders
Q4 2022175,000$196.0K<0.1%00.0%UnchangedHolders
Q3 2022175,000$197.0K<0.1%00.0%UnchangedHolders
Q2 2022175,000$257.0K<0.1%00.0%UnchangedHolders
Q1 2022175,000$400.0K<0.1%00.0%UnchangedHolders
Q4 2021175,000$481.0K<0.1%00.0%UnchangedHolders
Q3 2021175,000$1.05M<0.1%00.0%UnchangedHolders
Q2 2021175,000$852.0K<0.1%00.0%UnchangedHolders
Q1 2021175,000$432.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.